4-(2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl)phenol
| Title | Journal |
|---|---|
| Contraceptives with novel benefits. | Expert opinion on investigational drugs 20120101 |
| Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy. | International journal of women's health 20120101 |
| A randomized, controlled pilot trial of hormone therapy for menopausal insomnia. | Archives of women's mental health 20111201 |
| [Effect of trimegestone on mammary gland of castrated rats]. | Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 20110701 |
| Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. | Steroids 20110601 |
| Metabolic effects of contraceptive steroids. | Reviews in endocrine & metabolic disorders 20110601 |
| The use of newer progestins for contraception. | Contraception 20101101 |
| The haunting of medical journals: how ghostwriting sold 'HRT'. | PLoS medicine 20100901 |
| Identification of genes influencing skeletal phenotypes in congenic P/NP rats. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100601 |
| Presence of steroid hormones and antibiotics in surface water of agricultural, suburban and mixed-use areas. | Environmental monitoring and assessment 20090701 |
| Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone. | Maturitas 20090320 |
| Evaluation of extended and continuous use oral contraceptives. | Therapeutics and clinical risk management 20081001 |
| Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone. | Thrombosis and haemostasis 20080801 |
| Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms. | Climacteric : the journal of the International Menopause Society 20080401 |
| Pharmacological profile of progestins. | Maturitas 20080101 |
| Classification and pharmacology of progestins. | Maturitas 20080101 |
| Free synthetic and natural estrogen hormones in influent and effluent of three municipal wastewater treatment plants. | Water environment research : a research publication of the Water Environment Federation 20070901 |
| Preclinical and clinical properties of trimegestone: a potent and selective progestin. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070601 |
| Current state of hormone replacement therapy: the case for using trimegestone. | Women's health (London, England) 20060701 |
| Which progestogen is more likely to increase the risk of fatal myocardial infarction: a combination of epidemiological and trial evidence. | Maturitas 20060520 |
| Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell. | Molecular human reproduction 20060301 |
| New progestagens for contraceptive use. | Human reproduction update 20060101 |
| Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. | The Journal of steroid biochemistry and molecular biology 20051201 |
| Pharmacology of different progestogens: the special case of drospirenone. | Climacteric : the journal of the International Menopause Society 20051001 |
| Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050901 |
| Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget. | The Journal of biological chemistry 20050805 |
| Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050801 |
| A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050801 |
| A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050801 |
| Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat. | The Journal of steroid biochemistry and molecular biology 20050301 |
| Sleep apnea and hormone replacement therapy: a pilot study and a literature review. | Acta obstetricia et gynecologica Scandinavica 20050101 |
| Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women. | Climacteric : the journal of the International Menopause Society 20040901 |
| Pharmacological profile of progestins. | Maturitas 20040415 |
| Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. | Menopause (New York, N.Y.) 20040101 |
| New progestogens: a review of their effects in perimenopausal and postmenopausal women. | Drugs & aging 20040101 |
| Classification and pharmacology of progestins. | Maturitas 20031210 |
| The preclinical biology of a new potent and selective progestin: trimegestone. | Steroids 20031101 |
| Clinical experience with trimegestone as a new progestin in HRT. | Steroids 20031101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20031101 |
| Hormone therapy and the cardiovascular system: the critical role of progestins. | Climacteric : the journal of the International Menopause Society 20031001 |
| Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. | The Journal of clinical endocrinology and metabolism 20030901 |
| Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women. | British journal of haematology 20021201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021101 |
| Effects of hormone replacement therapy on blood platelets. | European journal of clinical investigation 20020801 |
| [Pharma-Clinics. Medication of the month. Totelle Cycle: new sequential estrogen/progesterone regimen for hormone replacement therapy in menopause]. | Revue medicale de Liege 20020601 |
| The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study. | Human reproduction (Oxford, England) 20020501 |
| Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20020401 |
| Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women. | Journal of internal medicine 20020301 |
| Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. | Menopause (New York, N.Y.) 20020101 |
| Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate. | Climacteric : the journal of the International Menopause Society 20011201 |
| A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20011001 |
| Trimegestone: expanding therapeutic choices for the treatment of the menopause. | Expert opinion on investigational drugs 20010901 |
| Effects of 17 beta-estradiol and trimegestone alone, and in combination, on the bone and uterus of ovariectomized rats. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20010801 |
| Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone. | The Journal of steroid biochemistry and molecular biology 20010801 |
| Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20010201 |